secwatch / observer
8-K filed October 23, 2026, 6:07 AM ET ticker ZYME CIK 0001937653
M&A confidence high sentiment positive materiality 0.85

Zymeworks licenses DLL3 T-cell engager ZW209 to Roche for $55M upfront, up to $758M in milestones

Zymeworks Inc.

Zymeworks Inc. filing history →

Source: SEC EDGAR
accession 0001937653-26-000055
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.